| 2025/0114,415 | METHOD FOR LOWERING CHOLESTEROL AND LIPID LEVELS USING THE ANTRODIA CINNAMOMEA WATER-INSOLUBLE DIETARY FIBER | Dec 20, 24 | Apr 10, 25 | Not available |
| 2025/0092,041 | PYRAZOLOPYRIDINE DERIVATIVE HAVING GLP-1 RECEPTOR AGONIST EFFECT | Nov 22, 24 | Mar 20, 25 | Chugai Seiyaku Kabushiki Kaisha |
| 2025/0082,706 | FERMENTED GINSENG RADIX ET RHIZOMA EXTRACT, PRODUCT FOR ALLEVIATING NON-ALCOHOLIC FATTY LIVER DISEASE, METHOD FOR PROMOTING INCREASE OF CONTENT OF AGLYCONE FLAVONOIDS AND/OR SHORT-CHAIN FATTY ACIDS IN GINSENG RADIX ET RHIZOMA EXTRACT, AND METHOD FOR PROMOTING EFFICACY OF GINSENG RADIX ET RHIZOMA EXTRACT IN ALLEVIATING NON-ALCOHOLIC FATTY LIVER DISEASE | Jun 18, 24 | Mar 13, 25 | INFINITUS (CHINA) COMPANY LTD. |
| 2025/0073,185 | Composition Including Benzylaminoethanol Derivative as Active Ingredient for Prevention or Treatment of Metabolic Disease | Jul 28, 22 | Mar 06, 25 | Not available |
| 2025/0064,926 | HUMAN ANTIBODIES TO PCSK9 FOR USE IN METHODS OF TREATING PARTICULAR GROUPS OF SUBJECTS | Jul 31, 24 | Feb 27, 25 | Not available |
| 2025/0066,509 | ANTI-BETAKLOTHO ANTIBODY AND USE THEREOF | Dec 29, 22 | Feb 27, 25 | Not available |
| 2025/0059,300 | METHODS FOR TREATING PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA (heFH) WITH AN ANTI-PCSK9 ANTIBODY | Jul 29, 24 | Feb 20, 25 | Not available |
| 2025/0059,540 | DOUBLE STRANDED RNA TARGETING ANGIOPOIETIN-LIKE 3 (ANGPTL-3) AND METHODS OF USE THEREOF | Jun 28, 24 | Feb 20, 25 | Not available |
| 2025/0051,765 | APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF | Apr 29, 24 | Feb 13, 25 | Not available |
| 2025/0051,457 | ASGR INHIBITORS | Jul 11, 24 | Feb 13, 25 | Not available |
| 2025/0041,264 | METHOD FOR TREATING DIABETES BY USING ANTRODIA CAMPHORATA COMPOUND | Jan 24, 24 | Feb 06, 25 | Not available |
| 2025/0032,446 | METHODS AND COMPOSITIONS FOR THE BIOSYNTHESIS AND USE OF DEMETHYLATED POLYMETHOXY FLAVONES | Dec 12, 22 | Jan 30, 25 | Board of Trustees Rutgers The State University of New Jersey |
| 2025/0025,421 | PREPARATION IN SOLID FORM COMPRISING ACTIVATED CARBON AND CHITOSAN, METHOD FOR PREPARING SAID PREPARATION, COMPOSITION COMPRISING SAID PREPARATION AND USES OF SAID COMPOSITION | Jun 10, 22 | Jan 23, 25 | Not available |
| 2025/0025,538 | METHODS FOR TREATING LYSOSOMAL ACID LIPASE DEFICIENCY IN PATIENTS | Aug 08, 24 | Jan 23, 25 | Not available |
| 2025/0026,803 | IMMUNOGLOBULINS AND USES THEREOF | Oct 02, 24 | Jan 23, 25 | Not available |
| 2025/0027,089 | DOUBLE STRANDED RNA TARGETING PROPROTEIN CONVERTASE SUBTILISIN KEXIN 9 (PCSK9) AND METHODS OF USE THEREOF | Jun 21, 24 | Jan 23, 25 | Not available |
| 2025/0017,998 | SP-8356, EMODIN, AND IT603 ENHANCE BEIGE ADIPOCYTE ACTIVITY AND ALLEVIATE OBESITY AND DIABETES VIA UNCOUPLING PROTEIN 1 (UCP1)-INDEPENDENT MECHANISM | Jul 03, 24 | Jan 16, 25 | Not available |
| 2025/0019,353 | BENZOTHIA(DI)AZEPINE COMPOUNDS AND THEIR USE AS BILE ACID MODULATORS | Jul 02, 24 | Jan 16, 25 | Not available |
| 2025/0009,840 | CHOLESTEROL-FREE HIGH-DENSITY LIPOPROTEIN PARTICLES | Oct 04, 22 | Jan 09, 25 | PhoenixBio Co., Ltd. |
| 2025/0009,842 | Methods for Regulating Muscle Performance using Fat Specific Protein 27 (FSP27) Compositions | Aug 13, 24 | Jan 09, 25 | Ohio University |